Brain Correlates of Self-Focused Processing

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether neuroimaging-based markers of maladaptive self-focused processing are better predictors of treatment response to cognitive-behavioral therapy than behavioral markers.

Clinical Trial Description

First, the investigators propose to identify the neural correlates of self-focused processing. The investigators will assess baseline resting state connectivity within the default network, as well as regional brain activation using a well-validated event-related fMRI task that manipulates self-focused processing in patients with body dysmorphic and socially anxious symptoms, compared to healthy controls. This clinical sample was selected because such patients display heightened self-focused attention, and sampling individuals across these symptom dimensions will ensure greater variability on this dimension of maladaptive self-focused processing. Second, the investigators will examine the neural correlates of self-focused processing as a predictor of treatment response. Neuroimaging data will be acquired from patients with body dysmorphic and socially anxious symptoms during two scan sessions, before and after 12 weeks of individual cognitive behavioral therapy, and compared with healthy controls scanned twice at a 12 week interval. Finally, the investigators will compare the prediction of treatment response between neural measures and behavioral measures of self-focused processing. The investigators will assess the behavioral correlates of self-focused processing using a self-reference effect paradigm, and assess their relation to treatment response. If the investigators hypotheses are borne out, the investigators will have new targets for treatment, a method to identify promising candidates for treatment, and sensitive surrogate markers of treatment response. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02808702
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2017
Completion date	March 13, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02256566` - Cognitive Training for Mood and Anxiety Disorders	N/A
Completed	`NCT01570400` - Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT	N/A
Recruiting	`NCT01388231` - Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice	Phase 2/Phase 3
Completed	`NCT00684541` - Interpretation Modification Program for Social Phobia	N/A
Completed	`NCT00434759` - Social Phobia Intervention Study of Mannheim	N/A
Completed	`NCT00380731` - Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia	N/A
Completed	`NCT03647605` - Pilot Study: VR Mind and VR Mind+ Intervention	N/A
Not yet recruiting	`NCT03241277` - Nonsurgical Periodontal Treatment in Patients With Social Phobia	N/A
Completed	`NCT02648737` - Cognitive Behavioural Therapy for Anxiety Disorders in PD	N/A
Completed	`NCT02294409` - Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis	N/A
Terminated	`NCT01979263` - Attention Bias Modification Treatment for Anxious Youth	N/A
Completed	`NCT01463137` - Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder	N/A
Completed	`NCT00774150` - Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study	N/A
Completed	`NCT00264654` - Long-term Study Of Paroxetine in Women and Men	Phase 3
Completed	`NCT00326430` - Residential Cognitive and Interpersonal Therapy for Social Phobia	Phase 2/Phase 3
Completed	`NCT00000389` - Treatment for Anxiety in Children	Phase 3
Completed	`NCT00397722` - Treatment Of Patients With Social Anxiety Disorder	Phase 2
Completed	`NCT02678624` - Project Collabri for Treatment of Anxiety	N/A
Completed	`NCT00564967` - A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy	Phase 3
Completed	`NCT00403962` - A Combination Therapy In Patients With Social Anxiety Disorder	Phase 2